Medico Remedies Limited (BOM:540937)

India · Delayed Price · Currency is INR

40.65

+2.45 (6.41%)

At close: Jul 27, 2026

Medico Remedies Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	2,064	2,064	1,509	1,449	1,404	1,210
Revenue Growth	36.73%	36.73%	4.15%	3.19%	16.04%	-1.12%
Gross Profit	550.5	550.5	407.01	336.79	347.51	322.8
Operating Income	139.32	139.32	119.73	100.3	68.99	51.55
Net Income	131.15	131.15	100.93	82.91	72.42	48.12
Earnings Per Share	1.58	1.58	1.22	1.00	0.87	0.58
EPS Growth	29.90%	29.90%	21.74%	14.84%	50.03%	85.79%

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	37.51	37.51	25.46	15.46	21.77	23.44
Total Debt	192.04	192.04	147	80.5	97.62	125.97
Net Cash (Debt)	-154.53	-154.53	-121.54	-65.05	-75.85	-102.53
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.86	-1.86	-1.46	-0.78	-0.91	-1.24

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	58.74	58.74	48.92	24.38	81.67	58.62
Capital Expenditures	-44.9	-44.9	-31.87	-24.78	-65.92	-59.13
Free Cash Flow	13.85	13.85	17.05	-0.4	15.75	-0.51
Free Cash Flow Growth	-18.79%	-18.79%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	26.67%	26.67%	26.96%	23.24%	24.75%	26.67%
Operating Margin	6.75%	6.75%	7.93%	6.92%	4.91%	4.26%
Pretax Margin	8.75%	8.75%	8.95%	7.82%	7.19%	5.36%
Profit Margin	6.35%	6.35%	6.69%	5.72%	5.16%	3.98%
FCF Margin	0.67%	0.67%	1.13%	-0.03%	1.12%	-0.04%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 28, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	27.20	20.65	42.84	49.33	85.60	28.97
P/FCF Ratio	257.61	195.64	253.61	-	393.61	-
PS Ratio	1.73	1.31	2.86	2.82	4.41	1.15